Olfid 5 & 10 5mg, 10 mg Tablets
PDF Leaflet Revision Date: 26 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Improves glycaemic control in adults with type 2 diabetes mellitus.
Dosage (summary)
10 mg once daily for adults; lower doses may be needed with insulin or insulin secretagogues.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Diuretics
- Insulin
- Insulin secretagogues
Contraindications
- Hypersensitivity to dapagliflozin
- Moderate/severe renal impairment
- Type 1 diabetes
- Pregnancy
- Breastfeeding
Common side effects
- Hypoglycaemia
- Dizziness
- Urinary tract infections
- Genital infections
Counselling Points
- Monitor for signs of ketoacidosis
- Stay hydrated
- Report genital infections immediately
Serious warnings
- Risk of metabolic acidosis
- Risk of diabetic ketoacidosis
- Risk of Fournier's gangrene
Important Disclaimer
The Olfid 5 & 10 5mg, 10 mg Tablets professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
